NextDay Inspect Expands Premier Home Inspection and Environmental Services into West Virginia
Sterling, Virginia, United States, July 5, 2025 -- This strategic expansion reflects NextDay Inspect®'s commitment to making the real estate transaction process smoother and more transparent for a wider range of clients. Known for their rapid report turnaround (typically within 48 hours), thorough assessments, and use of advanced technology like thermal imaging, NextDay Inspect® aims to bring the same level of quality and customer focus to these growing West Virginia communities.
Bringing Comprehensive Services to West Virginia
Residents, buyers, sellers, and real estate professionals in Jefferson, Berkeley, and Morgan counties can now benefit from NextDay Inspect®'s extensive service offerings, including:
Commitment to Quality and Client Satisfaction
NextDay Inspect®'s expansion is built on the same core values that have established its reputation in the DMV area: reliability, precision, and exceptional customer service. The company understands the significance of buying or selling a property and strives to provide clients with the detailed information and peace of mind needed to make confident decisions.
'We are thrilled to bring our trusted services to Jefferson, Berkeley, and Morgan counties,' said Khaled Alkurd, Operations Coordinator for NextDay Inspect®. 'Our goal is to empower property owners and buyers in West Virginia with the same high-quality inspections and rapid, reliable reporting that our clients in Virginia, Maryland, and DC have come to expect. We look forward to becoming a valued partner in the local real estate community.'
The expansion into West Virginia marks a significant milestone for NextDay Inspect®, reinforcing its position as a premier inspection service provider in the Mid-Atlantic region.
Expanding Our Reach
The expansion of NextDay Inspect® into Jefferson, Berkeley, and Morgan counties marks a significant step in providing accessible, high-quality home inspection and environmental testing services to the West Virginia eastern panhandle. By extending its proven model of thorough assessments, advanced technology, rapid reporting, and dedicated customer service, NextDay Inspect® aims to simplify the real estate process and empower clients in these new service areas to make informed decisions about their properties with confidence and peace of mind.
About the company: NextDay Inspect® is a premier provider of comprehensive home inspection and environmental testing services across Washington D.C., Maryland, Virginia, and the eastern panhandle of West Virginia (Jefferson, Berkeley, and Morgan counties). Utilizing advanced technology and delivering detailed reports typically within 48 hours, NextDay Inspect® empowers homebuyers, sellers, and real estate professionals to make informed property decisions with confidence and clarity. The company is committed to providing reliable, thorough, and timely assessments to ensure a smooth and transparent real estate transaction process. Learn more at https://nextdayinspect.com/.
Contact Info:
Name: Khaled Alkurd
Email: Send Email
Organization: NextDay Inspect®
Address: 46179 Westlake Dr #200, Sterling, VA 20165
Phone: 703-450-6398
Website: https://nextdayinspect.com/
Video URL: https://youtu.be/tBy1sMicEyE?si=wfA_DvQAGfbo1IBS
Release ID: 89158637
In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
an hour ago
- The Hill
Blackstone executive killed in NYC shooting ID'd: ‘Beloved member of the Blackstone family'
NEW YORK (WPIX) – Blackstone executive Wesley LePatner was identified as one of the victims killed in the mass shooting at a Manhattan skyscraper. on Monday, according to a spokesperson for the company. LePatner was the Global Head of Core+ Real Estate and the CEO of Blackstone Real Estate Income Trust (BREIT), according to Blackstone's website. 4 victims, including police officer, killed in Manhattan mass shooting: NYPD 'Words cannot express the devastation we feel. Wesley was a beloved member of the Blackstone family and will be sorely missed,' a representative for the investment company said in a statement. LePatner's colleagues described her as 'brilliant, passionate, warm, generous, and deeply respected within our firm.' According to her LinkedIn profile, LePatner spent more than a decade at the company after previously working for Goldman Sachs. She was a Yale graduate and also sat on the board of the Metropolitan Museum of Art. NYC gunman wanted to 'preserve brain' for research after shooting: Adams LePatner was one of four people shot and killed by 27-year-old Shane Tamura from Las Vegas, when he opened fire inside a Manhattan skyscraper around 7 p.m. on Monday. Authorities say the Blackstone executive took cover behind a pillar before the gunman began shooting into the building's lobby. Police officer Didarul Islam, a building security guard and a person in the building's Rudin Management office were also killed in the mass shooting, officials have reported. An NFL staffer was also shot and has been listed in critical condition. New York City Mayor Eric Adams visited the scene on Monday and confirmed that Tamura had had died from an apparent self-inflicted gunshot wound.
Associated Press
4 hours ago
- Associated Press
Arixa Capital Surpasses $6 Billion in Loan Originations
LOS ANGELES, July 29, 2025 /PRNewswire/ -- Arixa Capital, a leading private real estate lender, announced it has surpassed $6 billion in loan originations since inception. The company provides short-term loans ranging from $250,000 to $70 million to finance the acquisition, construction and/or renovation of single family, multifamily, and large-scale subdivision projects. 'In an uncertain market, reliability stands out,' said Greg Hebner, Managing Director. 'Arixa's growth to $6 billion is the result of our relentless focus on being a dependable capital partner, executing with speed and certainty, and striving to deliver service that goes above and beyond.' Six Figures That Tell the Story Behind the $6 Billion1 Arixa's growth has been driven by its commitment to delivering for clients. The six figures below highlight how that approach has fueled our trajectory. 750+ Clients Backed Across 20 U.S. States More than 750 professional real estate investors, developers, and builders across 20 states have turned to Arixa for its blend of local market expertise with the scale of a national platform. 100% of Credit Decisions Made In-House As a balance sheet lender, Arixa retains control over underwriting and approvals, allowing for more flexible terms, direct access to decision-makers, and certainty of closing in 10–14 days. 3–5 Days for Draws Arixa processes draw requests in-house, typically within 3–5 days. Each loan is managed by a dedicated team who stays with the client from underwriting to payoff to help reduce delays. 10,000+ Housing Units Built or Renovated Arixa has helped finance the construction or renovation of over 10,000 housing units across the U.S., representing a tangible contribution towards the national housing shortage. 95% Net Promoter Score2 With a 95/100 client satisfaction score, Arixa ranks among the top-performing lenders. This score is reflected in the high volume of repeat business from long-term clients. $1.7 Billion Over the Past Year Alone As banks retreated after the regional banking crisis, Arixa built a reputation as a reliable and resilient capital partner, driving over $1.7 billion in loan originations over the past 12 months. 'We haven't reached this $6 billion milestone alone,' added Seth Davis, Managing Director. 'This achievement reflects the trust of our institutional and fund investors, whose continued support has powered 15 years of strong partnership, performance, and capital preservation across market cycles.' With rising demand for dependable capital and the continued tightening from banks, Arixa Capital plans to expand its reach across key U.S. markets. The company recently announced additions to its loan origination team in Arizona, Colorado, Minnesota, and Texas. About Arixa Capital Founded in 2006, Arixa Capital is a leading private real estate lender and alternative investment manager with over $6.0 billion in originations completed since inception and over $1.8 billion of assets under management as of June 30, 2025. As an independent, employee-owned firm, we are personally invested in the success of our borrowers and investors. Our reputation for reliability, transparency, and exceptional service inspires long-term relationships and is the foundation of our growth and success. Arixa has been named one of the fastest growing private companies according to the Inc. 5000.3 The firm has offices in Los Angeles and Phoenix. To learn more about Arixa Capital, please contact: Greg Hebner Managing Director [email protected] Seth Davis Managing Director [email protected] For media inquiries, please contact: Steve Pavlov Vice President, Marketing [email protected] Endnotes 1All figures are based on Arixa Capital internal data as of June 30, 2025. 2The Net Promoter Score ('NPS') is a widely used measure of client satisfaction and loyalty, based on how likely clients are to recommend a company to others. The NPS calculation involves subtracting the percentage of detractors from the percentage of promoters, resulting in a number ranging from -100 to 100, where a higher score indicates a more loyal customer base. According to Bain & Company, the average NPS for U.S. SMB banks is 43/100. For more information about NPS methodology, please go to 3Arixa provided Inc. de minimis compensation to be considered for the Inc. 5000 list of the fastest growing private companies in the U.S. For a full description of ranking methodology, please visit: View original content to download multimedia: SOURCE Arixa Capital Advisors, LLC
Yahoo
5 hours ago
- Yahoo
Merck to cut jobs and costs as demand for Gardasil in China remains weak
By Michael Erman (Reuters) -Drugmaker Merck & Co on Tuesday announced job and cost cuts it said will save $3 billion a year as it posted lower second-quarter results due to continuing weak demand for its Gardasil vaccine in China. The company said the cost cuts include $1.7 billion in annual savings from the elimination of certain administrative, sales and R&D positions. It also plans to reduce its global real estate footprint and optimize its manufacturing network. Chief Executive Rob Davis said in a press release that the moves "will redirect investment and resources from more mature areas of our business to our burgeoning array of new growth drivers." The company expects to achieve the full $3 billion in annual savings by the end of 2027. Investors have been concerned about where Merck will replace revenue from its blockbuster cancer treatment Keytruda - the world's best-selling drug, which is set to lose patent protection toward the end of the decade. Gardasil's problems in China have also been a drag on the company's results. Merck said it earned $5.4 billion, or $2.13 a share, in the quarter, down from $5.8 billion, or $2.28 a share, a year earlier. Analysts, on average, had forecast earnings of $2.01 a share. Merck's quarterly R&D costs were lower than expected. Revenue in the quarter was $15.8 billion, down from $16.1 billion a year earlier. Analysts, on average, were expecting revenue of $15.9 billion. Gardasil sales missed already weak Wall Street estimates. The company said it sold $1.1 billion of the vaccine, which prevents cancer caused by the human papillomavirus, down 55% from a year ago. Analysts had been expecting $1.3 billion of Gardasil sales in the quarter. Merck paused shipments of Gardasil to China in January. It said the decline was primarily in China, but lower demand in Japan had hurt sales as well. Sales of Keytruda rose 9% to just under $8 billion in the quarter, topping analyst forecasts of $7.9 billion. The company, which announced a $10 billion takeover of UK-based Verona Pharma earlier in July, narrowed its full-year revenue forecast to a range of $64.3 billion to $65.3 billion. It had previously forecast revenue of $64.1 billion to $65.6 billion for the year. It now expects to earn $8.87 to $8.97 a share in 2025. Analysts had forecast 2025 earnings to be $8.87.
